OT-101 (Development Center for Biotechnology (TW))

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameOT-101 (Development Center for Biotechnology (TW))
Drug Alias Namerecombinant factor IX (Development Center for Biotechnology)
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionCoagulation factor IX stimulants
TargetsCoagulation factor IX
Therapy Area/IndicationsHemophilia B
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryTaiwan
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesDevelopment Center for Biotechnology
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesDevelopment Center for Biotechnology
Active IndicationsN/A
Inactive IndicationsHemophilia B

Other Information

ATC CodeN/A
Related LinksN/A